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The goal of tissue engineering and regenerative medicine is to develop synthetic versions
of human organs for transplantation, in vitro toxicology testing and to understand basic
mechanisms of organ function. A variety of different approaches have been utilized to repli-
cate the microenvironments found in lymph nodes including the use of a variety of different
bio-materials, culture systems, and the application of different cell types to replicate stro-
mal networks found in vivo. Although no system engineered so far can fully replicate lymph
node function, progress has been made in the development of microenvironments that can
promote the initiation of protective immune responses. In this review we will explore the
different approaches utilized to recreate lymph node microenvironments and the technical
challenges required to recreate a fully functional immune system in vitro.
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OVERVIEW OF LYMPH NODE STRUCTURE
Immune responses in mammals are coordinated from secondary
lymphoid organs (SLOs) that are positioned at strategic loca-
tions throughout the body. Naïve T and B cells continuously pass
through SLO while navigating the bloodstream. Within the SLO,
T and B cells scan for the presence of their cognate antigen. In
the absence of antigen recognition, cells receive homeostatic sur-
vival signals allowing them to continue their journey to the next
SLO. On the other hand, when T or B cells do recognize antigen,
the SLOs provide an optimal environment for cellular activation,
proliferation, and selection for high afﬁnity antibodies.
To facilitate optimal lymphocyte activation, SLOs are compart-
mentalized into distinct cellular micro-domains that are colonized
almost exclusively by either TorB cells (Crivellato et al., 2004). The
generation and maintenance of B cell follicle and the T cell zone is
critically dependent on cytokines, adhesion molecules, and extra-
cellular matrix proteins made by non-hematopoietic stromal cells
(Cyster, 2005; van de Pavert andMebius, 2010). A thoroughunder-
standing of the non-hematopoietic microenvironment of SLO
is therefore indispensable for lymphoid organ tissue-engineering
(Mueller and Germain, 2009).
MESENCHYMAL STROMAL CELLS
Three major subsets of functionally distinct stromal cells of mes-
enchymal origin are currently recognized in human and mouse
lymph nodes.
T ZONE RETICULAR CELLS
T zone reticular cells [TRC, also known as ﬁbroblastic reticular
cells (FRCs)] are the major mesenchymal stromal population in
the T cell areas of the lymph nodes, located at the medullary side
of the B cells follicles (Kaldjian et al., 2001; Katakai et al., 2004a;
Link et al., 2007). Phenotypic, TRC are characterized by expression
of podoplanin (gp38, D240) alpha-smooth muscle actin (αSMA)
and theproductionof extracellularmatrix components recognized
by the antibody ERTR7 (Van Vliet et al., 1984). On a functional
level, TRC secrete the homeostatic chemokines CCL21 and CCL19
which act on naïve T cells and dendritic cells (DCs), respectively
(Link et al., 2007). Structurally, TRC provide a scaffold to which
DC that came in through the lymph are anchored and which is
used by naïve T cells to navigate the lymph node in search for DC
(Bajénoff et al., 2006).
FOLLICULAR DENDRITIC CELLS
Follicular dendritic cells (FDCs) are located within primary B cell
follicles in resting lymph nodes and in the light zone of germi-
nal centers during immune responses (Chen et al., 1978). In spite
of their name, FDCs are not DCs and do not possess antigen
processing machinery but rather are radio-resistant stromal cells
of mesenchymal origin (Endres et al., 1999; Krautler et al., 2012).
FDCs are decorated by complement receptors and Fc receptors
and they use these to present unprocessed immune complexes to
B cells during germinal center reactions, when B cells that have
undergone somatic hypermutation test newly generated receptors
for improved afﬁnity (Kosco-Vilbois and Scheidegger, 1995). In
addition, FDCs secrete the B cell chemoattractant CXCL13 that
is essential to maintain the structural integrity of the B cell fol-
licle under homeostatic conditions (Cyster et al., 2000; Allen and
Cyster, 2008; Suzuki et al., 2010; Wang et al., 2011).
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MARGINAL RETICULAR CELLS
The third major mesenchymal cell type in lymph nodes are
marginal reticular cells (MRCs), which are found in the outer
cortex, directly underneath the subcapsular sinus (Katakai et al.,
2008). MRCs have been identiﬁed in both mouse (Katakai et al.,
2008) and human (T. Cupedo and M. Coles, unpublished data)
lymph nodes. Phenotypically MRCs resemble so-called lym-
phoid tissue organizer (LTo) cells that are responsible for lymph
node development in the embryo (Cupedo et al., 2004; Katakai
et al., 2008; Katakai, 2012). Adult lymph node MRCs express
RANKL,VCAM-1, MAdCAM-1, and podoplanin and they secrete
homeostatic chemokines (Katakai et al., 2008). The physiological
importance of MRCs in lymph node functioning remains in large
parts to be elucidated, but these cells were shown to be involved
in the shuttling of antigens from the marginal sinus to the B cell
follicles (Roozendaal et al., 2009).
ENDOTHELIAL CELLS
There are two major types of vascular network that provide nutri-
ents, oxygen, and cellular input and output from the lymph
node.
BLOOD ENDOTHELIAL CELLS
Blood vessels enter and exit the lymph node at the medullary hilus
area. In the paracortical T cell zone, the smaller venules take on a
characteristic cubical appearance and are known as high endothe-
lial venules (HEV;Miyasaka and Tanaka, 2004). These HEV are the
main points of entry for naïve T and B lymphocytes. They express
adhesionmolecules and addressins and are decoratedwith stromal
cell-derived chemokines. In the absence of functional HEV, recir-
culation of naïve lymphocytes, and thus immune surveillance, are
severely impaired (von Andrian and Mempel, 2003).
LYMPHATIC ENDOTHELIAL CELLS
Lymphatic endothelium is recognized by the characteristic expres-
sion of the receptor Lyve-1 (Banerji et al., 1999). Afferent lym-
phatic vessels originating in peripheral tissues carry lymph to
draining lymph nodes (Oliver and Alitalo, 2005). This lymph
also contains free as well as cell-bound antigens. The lymph
vessels end in the subcapsular sinus, a lymphatic sinus that is
located directly underneath the lymph node capsule (McMaster
and Hudack, 1935; Oliver and Alitalo, 2005). From the sinus,
larger antigens (>70 kDa) can be captured by lymph node-
resident subcapsular macrophages or are carried by migratory
antigen-presenting cells including DCs and neutrophils into the
organ (Junt et al., 2007), smaller antigens can enter by diffusion
through the conduit network and be captured by antigen pre-
senting cells in the lymph node (Carroll and Isenman, 2012).
Efferent lymphatic vessels originate in the lymph node hillus and
allow cells to leave the organ and re-enter the blood stream or
travel through the lymph to a subsequent lymph node (Forster
et al., 2012).
CAPTURING THE STRUCTURE AND COMPLEXITY OF A
LYMPH NODE
Despite their relative modest size, bio-engineering a lymph node
presents a formidable challenge due to the high level of com-
plexity resulting from the large variety of cell types, the highly
organized stromal and lymphoid structure, the rapid cellular
motility of lymphocytes and DCs and the staggering cell den-
sity (key features summarized in Figure 1). The multitude of cell
types and the scale of the engineering, with complex changes in
microenvironments occurring within a few microns, make engi-
neering a lymphnodemore complex than the engineering of larger
organs like the heart or kidneys. From immunohistological and
FIGURE 1 | Key features of an artificial lymph node.To recreate functional
lymph nodes in vitro several key constituents need to be incorporated. These
include speciﬁc stromal cells for T and B areas in order to generate the typical
microarchitecture. In addition, nutrients, oxygen, and antigens need to be able
to enter the organoid, while functional end products such as antibodies and
cytokines should be able to be extracted from the organ.
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ﬂow cytometric measurements it can be estimated that within
1 mm3 of lymph node tissue approximately 1 to 2 × 106 cells
reside, accounting for a cell density of about one billion cells/ml
(our unpublished data). Within this cell mass highly organized
lymphatics, marginal reticular zone stroma, T cell zone stroma,
multiple B cell follicles, vascular networks and medullary regions
containing plasma cells and macrophages are present which are
all highly different localized microenvironments (Crivellato et al.,
2004). Even in extremely high dense tissue culture, maximum
cell densities are in the range of 5 to 10 × 106 cells/ml, which
is two orders of magnitude less dense, indicating that there is
hardly any liquid phase within the lymph node parenchyma just
a compact cellular environment where cellular interactions and
cell–extracellular matrix interactions dictate rapid cell migration.
The lack of a liquid interface indicates that free diffusion of
cytokines, chemokines, and growth factors is unlikely to occur
by a simple gradient as observed in vitro assay systems and rather
is controlled through direct contact with the stromal network that
produce homeostatic chemokines and cytokines, sequestration of
these factors by extracellular matrix and by the rapid motility
of cytokine-secreting activated lymphocytes in the lymph node.
All of these effects indicate that vast differences exist between to
the biology measured in a culture dish and the biology opera-
tional in vivo that needs to be recapitulated in the bio-engineered
lymph node.
SOURCE OF MESENCHYME
Stromal cells provide the structural basis for both lymph node
structure and function and their faithful incorporation into an in
vitro system is thus a necessity for creation of a functional artiﬁcial
lymph node environment. A prerequisite for lymph node mod-
eling is therefore the establishment of mesenchymal cell cultures
that can take on the function of lymph node stromal cells found
in vivo. Unlike most other organs that involve layers of epithe-
lium and ﬁbroblasts or endothelium and muscle cells, the lymph
node stroma contains an open lattice network of different types of
mesenchymal stromal cells that permits rapid motility of immune
cells.
There are three main practical approaches that can be uti-
lized to generate mesenchymal cells for use in tissue engineering:
(1) the application of immortal ﬁbroblastic cell lines from a variety
of different tissues (Suematsu and Watanabe, 2004; Tomei et al.,
2009), (2) the use of primary stromal cells isolated from lymph
nodes (Tomei et al., 2009), and (3) the differentiation of lymph
node stroma from mesenchymal progenitor cells (Benezech et al.,
2012; Zheng et al., 2012). Although ﬁbroblastic cell lines from
non-lymphoid tissues are easy to culture they are unlikely to mir-
ror the gene expression pattern found in FRCs or FDCs. The
culture of primary stromal cells from lymph nodes has been chal-
lenging, and this has only been successfully accomplished by a
few groups (Katakai et al., 2004b; Onder et al., 2012). Prolonged
culture of these cells has led to a loss of phenotype requiring sup-
plement of the cells with exogenous cytokines and chemokines
(Suto et al., 2009). Differentiation of lymphoid stromal subsets
from progenitor cells would be the most ideal method to acquire
lymphoid stromal cells, but reproducible protocols have not yet
been developed.
THE OXYGEN CHALLENGE
Vascular networks are both the site of cellular input and egress
from lymph nodes but more importantly they provide the high
levels of oxygen and nutrients required by highly motile immune
cells. Any structure larger than 80–100 μm will become highly
hypoxic in the absence of oxygen supply and this problem is
ampliﬁed in lymph nodes, which have highly motile cells and
have a cell density of one billion cells/ml (our unpublished data).
One of the key engineering challenges in developing an artiﬁ-
cial lymph node is providing an environment that can support
the oxygen need of the lymph node environment. Possible sce-
narios include limiting the organ size, lowering the cell density,
or providing artiﬁcial blood vascular networks or hollow ﬁbers
for gas diffusion and nutrient supply (Zheng et al., 2012). Arti-
ﬁcial vascular beds can be generated through the formation of
microﬂuidic networks in bio-compatible gels. These networks
can be seeded with endothelial cells and vascular smooth mus-
cle cells leading to the development of vascular networks that
can support vascular sprouting and would lead to the incor-
poration of a highly structured vasculature in vitro (Zheng
et al., 2012). Even though including functional vascular net-
works into engineered organs will be technically challenging,
incorporation of the efﬁcient transport of oxygen and nutrients
into the organoid is essential for capturing normal lymph node
function.
TOWARD 3D CULTURE
A variety of different cellular approaches have been used by bio-
engineers to recreate tissues and organs in vitro. These include
three-dimensional (3D) culture of cells in extracellular matrix
or on artiﬁcial materials (Tomei et al., 2009), the formation of
spheroids (Lin and Chang, 2008), use of de-cellularized tissues
(Mirsadraee et al., 2006), and cell printing (Guillotin and Guille-
mot, 2011). Culturing of cells in a 3D environment for tissue
engineering and regenerative medicine has been performed on
a number of different types of materials all with their inherent
advantages and disadvantages.
Non-biological materials include sponges, synthetic polymers
and peptide hydrogels, electrospun polycarbonate ﬁbers, and
synthetic multilayer surfaces.
Electrospun ﬁbers and multilayer surfaces provide a 3D sur-
face that permits attachment and growth of stromal cells in 3D
(Holmes et al., 2012). The disadvantage of this technology is that
in essence it is a 3D environment where cells grow in 2D, attached
to an inert material, leading to very different interactions between
stromal cells as they are not forming a 3D self-supporting net-
work. Moreover, interactions with lymphocytes and DCs will also
be fundamentally different from those observed in vivo as they
will interact only with non-adhered surface of stromal cells. Alter-
native synthetic matrices include sponges and polymer hydrogels
(Tibbitt and Anseth, 2009). Depending on the pore size, sponges
are essentially like electrospun polycarbonate, providing a mere
artiﬁcial substrate for cell growth. Polymer hydrogels form into
solid gels through the exclusion of water and condensation of
polymer, leading to the encapsulation of cells into the hydrogel
rather than the formation of 3D networks. These types of gels
work extremely well for cell types such as chondrocytes but are
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likely to be of limited application for engineering lymph node
environments.
Biological materials including agarose, laminin, Matrigel, ﬁb-
rin, and collagen gels are all commonly used in tissue engineering.
Agarose is an inexpensive material that is commonly used to cul-
ture hematopoietic colonies. Its advantages are the ability to be
formed into a variety of different tensile strengths and agarose
gels can be used to induce a certain level of cellular organiza-
tion. A major disadvantage of agarose is the fact that it cannot be
biologically restructured during culture, this restricts the mobil-
ity of cells and it is technically challenging to extract cells for
analysis, limiting its application. Matrigel is a mix of laminin,
ﬁbronectin, and collagen of an unknown constituency and is
commonly used in tissue engineering and tumor metastasis assays
(Hughes et al., 2010). Matrigel is secreted by a mouse tumor cell
line and probably represents a type of extracellular matrix nor-
mally deposited in tumor microenvironments and surrounding
blood vasculature. Despite its popularity, Matrigel cannot be eas-
ily remodeled by cells, and migration through Matrigel usually
involves digestion of the matrix by matrix metalloproteinase pro-
teins (MMPs), rather then active squeezing and crawling of cells
through the matrix (Lammermann et al., 2008). It is also very dif-
ferent in constituency to the type of extracellular matrix found
in lymph nodes. Collagen gels are commonly used in a variety
of tissue engineering applications and different types of collagens
are important components of extracellular matrix in a number
of organs including lymph nodes. Collagen I bundles form the
ﬂexible outer capsule of the lymph node and the conduits that
connect lymphatics to the HEVs providing structural support for
the stromal cell network and channels formovement of factors and
low molecular weight antigens into the parenchyma of the lymph
node (Lammermann et al., 2008). Collagen IV is secreted by TRC
and forms a layer of extracellular matrix around the these cells
(Sixt et al., 2005). To date, there is no evidence that this matrix
deposition is important to the structural integrity of the lymph
node. Collagen is a highly bio-compatible material and has been
applied to a number of different tissue engineering situations but
is easily contracted by cells when they apply force to the colla-
gen gel and is more challenging to work with due to its relative
low tensile strength in comparison to other biomaterials (Cross
et al., 2010).
Alternative tissue engineering approaches used to form 3D
organ-like cultures include spheroids which have been success-
fully utilized to study bone biology, endothelial cell outgrowths,
and the formation of breast and prostate tissues (Villadsen et al.,
2007). Spheroids are formed through the culture of cells in methyl
cellulose in hanging droplets, inducing the formation of a compact
tissue that can take on a higher degree of organization reminiscent
of the in vivo organ. Although this approach has worked well for
a variety of different tissues, the technology has to date not been
utilized for the formation of artiﬁcial lymph node microenviron-
ments. The main reason being that spheroids form into a very
compact cell aggregate which is fundamentally different from the
open lattice stromal cell network found in LNs.
Cell printing and encapsulation technology have been used
to form vascular networks and 3D bone structures (Fedorovich
et al., 2011). However, this technology lacks the resolution to be
of application when generating a complex structure like a lymph
node.
Capturing the complex structure of lymph nodes with separate
B and T cells zones is challenging. Most work to date has not
tried to impose structure upon the bio-engineered tissues rather
it has relied upon self-organization. In developing lymph node
B cells form into B cell follicles guided by a complex system of
stromal-derived chemokines (Mebius, 2003). Recapitulating the
appropriate signal in vitro will be essential for achieving organized
artiﬁcial lymphoid tissues.
CURRENT IN VITRO MODELS OF LYMPH NODE
MICROENVIRONMENTS
To recreate the lymph node environment a number of different
approaches have been utilized, and we will highlight several of
those here. For a more comprehensive overview of the existing
models see Kobayashi et al. (2011).
COLLAGEN/POLYURETHANE MATRIX
By combining type I collagen with polyurethane a composite
matrix was generated that provided sufﬁcient tensile strength to
counteract the contraction induced by the stromal cells seeded
in the matrix. Using immortalized TRC lines, it was convinc-
ingly shown that these cells not only behave totally different in
3D compared to 2D, but most importantly that culturing the
matrix under ﬂow induced structural remodeling and production
of chemokines (Tomei et al., 2009).
BIOREACTOR
In order to recreate immunological interactions rather then to
faithfully rebuild the lymph node structure, progress has been
made usingmembrane-based perfusion systems that can be seeded
with several types of matrices. After loading the bioreactor with
DCs and lymphocytes the production of inﬂammatory cyto-
kines as well as tissue architecture could be assessed (Giese et al.,
2006, 2010).
COLLAGEN SPONGE
The best results in terms of immune responses have been achieved
using collagen sponges, seeded with stromal cells and DC and
subsequently transplanted in mice. Even though these sponges
attract and organize B cells, form germinal centers and lead to
plasma cell differentiation in a very efﬁcient manner, they fall
beyond the scope of this review as most of the these features
are achieved in vivo (Suematsu and Watanabe, 2004; Okamoto
et al., 2007).
FUTURE DIRECTIONS AND CHALLENGES
A number of factors have limited the capacity to generate artiﬁcial
lymph nodes these include the size, the development of hypoxia in
larger tissues, and the engineering complexity of the lymph node.
One of the important engineering challenges will be to recreate
a compact environment in vitro complete with stromal networks
and to maintain cell motility, behavior, and function. This will
require developing tissue engineering on an immensely small scale,
the development of techniques to form stromal networks from
stem cell precursors, and methods to culture cells in very high
densities. So far a number of groups have shown that this can be
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done in vivo and some of the complexity has been mod-
eled in vitro using custom-designed bioreactors. Advancement
in bioreactor development and the culture of stromal cells
provides a platform for advancements in this bioengineering
challenge.
CONCLUSION
Over the last 15 years bio-engineers have developed novel arti-
ﬁcial organs that have started to appear in the clinic, one of
the great challenges left is to successfully develop an artiﬁcial
immune system that can reproduce complex immune responses in
vitro. Through designing and engineering artiﬁcial lymph nodes
immunologists will develop a tool that could be used to dissect
the molecular and biophysical mechanisms controlling human
immune responses in health and disease.
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